The two most common somatic mutations, an exon 19 in-frame deletion and a point mutation L858R at exon 21, account for ~85% of all EGFR mutations in NSCLC, particularly in LADC [5,6,7]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.